Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.

The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.

If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.

Related ACR News

  • CMS Proposes to Keep Excessive Radiation Dose eCQM Voluntary

    ACR urges members to contact CMS to keep the eCQM reporting voluntary indefinitely. The intent of CMS was to make the measure mandatory by 2027.

    Read more
  • House Spending Bill Emphasizes Medical Imaging

    The bill’s report language highlighted medical imaging, including under the National Cancer Institute.

    Read more
  • Review and Comment on the PP&TS Through Sept. 26

    Learn more about the PP&TS field review process and how this guidance helps radiology practices improve the quality and safety of patient care.

    Read more